ACTEMRA - 50242-135-04 - (tocilizumab)

Alphabetical Index


Drug Information of ACTEMRA

Product NDC: 50242-135
Proprietary Name: ACTEMRA
Non Proprietary Name: tocilizumab
Active Ingredient(s): 20    mg/mL & nbsp;   tocilizumab
Administration Route(s): INTRAVENOUS
Dosage Form(s): INJECTION, SOLUTION, CONCENTRATE
Coding System: National Drug Codes(NDC)

Labeler Information of ACTEMRA

Product NDC: 50242-135
Labeler Name: Genentech, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: BLA125276
Marketing Category: BLA
Start Marketing Date: 20100108

Package Information of ACTEMRA

Package NDC: 50242-135-04
Package Description: 4 VIAL, SINGLE-USE in 1 BOX (50242-135-04) > 4 mL in 1 VIAL, SINGLE-USE

NDC Information of ACTEMRA

NDC Code 50242-135-04
Proprietary Name ACTEMRA
Package Description 4 VIAL, SINGLE-USE in 1 BOX (50242-135-04) > 4 mL in 1 VIAL, SINGLE-USE
Product NDC 50242-135
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name tocilizumab
Dosage Form Name INJECTION, SOLUTION, CONCENTRATE
Route Name INTRAVENOUS
Start Marketing Date 20100108
Marketing Category Name BLA
Labeler Name Genentech, Inc.
Substance Name TOCILIZUMAB
Strength Number 20
Strength Unit mg/mL
Pharmaceutical Classes

Complete Information of ACTEMRA


General Information